Clinical Trial

HUmanitas PROtontherapy (HU-PRO)

Study acronym: HU-PRO
Recruiting
View on ClinicalTrials.gov →
Summary
Proton therapy is a cancer treatment, similar to the more commonly used radiation therapy. It uses radiation to destroy cancer cells and helps control the disease in the treated area. However, when proton therapy is compared with standard radiation therapy, many studies show fewer side effects and better disease control. This is due to the unique physical properties of the particles used in proton therapy. At present, in Italy, this innovative treatment is available only for selected diseases, as defined by national guidelines. For this reason, it is very important to collect as much data as possible to support the further development of proton therapy and to improve treatment safety and effectiveness.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-18.
Status change: Not Yet Recruiting → Recruiting 2026-01-19
Trial Details
NCT Number NCT07317245
Lead Sponsor Istituto Clinico Humanitas
Conditions Cancer, Proton Therapy
Enrollment 500 participants
Start Date 2026-01-12
Primary Completion 2036-01 (estimated)
Study Completion 2036-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-21